Treating the killer infection known as TB

Both MDR-TB and XDR-TB patients have to undergo a more intensive, longer-lasting and more expensive treatment regimen, which also comes with more significant side effects, compared to the normal TB treatment. — MSF filepic

Tuberculosis (TB) remains a persistent global health challenge, especially in low- and middle-income countries.

Poverty, overcrowding and limited access to healthcare create an environment that facilitates its continued spread.